Jison, Naneth S.
HRN: 24-08-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/15/2023
11/21/2023
IVT
2.25g
Q6
Intraabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes